Listen to the article 15 min This audio is auto-generated. Please let us know if you have feedback. This is …
Health Newswire™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC
Listen to the article 15 min This audio is auto-generated. Please let us know if you have feedback. This is …
NICE has said Biogen’s Tysabri can now be used by the NHS in England and Wales to treat highly active …
Listen to the article 5 min This audio is auto-generated. Please let us know if you have feedback. Botox has …
Months of uncertainty have come to a close. The BIOSECURE Act, now part of the National Defense Authorization Act (NDAA), …
Listen to the article 5 min This audio is auto-generated. Please let us know if you have feedback. Amylyx Pharmaceuticals …
Less than two years after buying Chinese biotech Gracell for its cell therapy platform, AstraZeneca has reported encouraging clinical results …
Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. When the …
With direct-to-consumer (DTC) sales of weight-loss therapies in the headlines almost every week, Waltz Health has entered the market with …
Listen to the article 5 min This audio is auto-generated. Please let us know if you have feedback. With TV …
The Trump administration has released details of a most-favoured nation (MFN) drug pricing programme for medicines provided by Medicaid, the …
Health-Newswire.Net™ aggregates, publishes and distributed news about the Healthcare industry. In association with EmailWire, Health-Newswire.Net™ provides press release distribution services in the Healthcare sector. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us through the following messaging apps:
Health Newswire™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC